Exercise reduces IOP and axial length in young adults

Article

Exercise can reduce intraocular pressure (IOP), ocular pulse amplitude (OPA) and axial length (AXL).

An experiment featured in Eye has demonstrated that exercise can reduce intraocular pressure (IOP), ocular pulse amplitude (OPA) and axial length (AXL).

Dr S. A. Read et al., Contact Lens and Visual Optics Laboratory, School of Optometry, Queensland University of Technology, Australia, studied 20 young adults. Ten of the participants were myopic and 10 were emmetropic.

Ocular biometrics, blood pressure, pulse rate IOP and OPA were measured during a rest period of 20 minutes. All participants then underwent 10 minutes of low intensity exercise. The measurements were taken again straight after, as well as 5 and 10 minutes after, the exercise. The groups were measured several times to analyse the changes in the measured parameters.

Although there were no significant differences between the emmetropic and myopic patients, the findings revealed that exercise significantly decreased AXL, and reduced IOP and OPA for both groups. There was a positive correlation between AXL changes and IOP changes. Exercise is significantly effective in positively influencing AXL and IOP in the short-term.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.